NCT02139488View on ClinicalTrials.gov

Organ Motion and Early Tumor Response Measurement

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 18, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Esophageal CancerChemoradiation
Interventions
OTHER

Fiducial markers

OTHER

Fiducial markers, Pet and MRI

Insertion of Fiducial markers in esophageal wall.

Trial Locations (1)

1066CX

The Netherlands cancer Institute, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT02139488 - Organ Motion and Early Tumor Response Measurement | Biotech Hunter | Biotech Hunter